GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (BUE:JNJ) » Definitions » Cash Flow from Financing

Johnson & Johnson (BUE:JNJ) Cash Flow from Financing : ARS-3,530,584 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Johnson & Johnson Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2024, Johnson & Johnson paid ARS284,820 Mil more to buy back shares than it received from issuing new shares. It received ARS1,550,350 Mil from issuing more debt. It paid ARS0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent ARS3,013,840 Mil paying cash dividends to shareholders. It received ARS394,910 Mil on other financial activities. In all, Johnson & Johnson spent ARS1,353,400 Mil on financial activities for the three months ended in Dec. 2024.


Johnson & Johnson Cash Flow from Financing Historical Data

The historical data trend for Johnson & Johnson's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cash Flow from Financing Chart

Johnson & Johnson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -498,045.58 -1,418,606.50 -1,487,223.11 -5,712,825.01 -3,163,320.03

Johnson & Johnson Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,680,455.00 460,005.01 6,755,651.90 -9,392,840.59 -1,353,400.01

Johnson & Johnson Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Johnson & Johnson's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

Cash Flow from Financing(A: Dec. 2024 )
=Issuance of Stock+Repurchase of Stock+Net Issuance of Debt+Net Issuance of Preferred Stock+Cash Flow for Dividends+Other Financing
=0+-2456320.025+10151510.102+0+-11941230.119+1082720.01
=-3,163,320

Johnson & Johnson's Cash from Financing for the quarter that ended in Dec. 2024 is:

Cash Flow from Financing(Q: Dec. 2024 )
=Issuance of Stock+Repurchase of Stock+Net Issuance of Debt+Net Issuance of Preferred Stock+Cash Flow for Dividends+Other Financing
=0+-284820.003+1550350.016+0+-3013840.03+394910.003
=-1,353,400

Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS-3,530,584 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Johnson & Johnson  (BUE:JNJ) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Johnson & Johnson's issuance of stock for the three months ended in Dec. 2024 was ARS0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Johnson & Johnson's repurchase of stock for the three months ended in Dec. 2024 was ARS-284,820 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Johnson & Johnson's net issuance of debt for the three months ended in Dec. 2024 was ARS1,550,350 Mil. Johnson & Johnson received ARS1,550,350 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Johnson & Johnson's net issuance of preferred for the three months ended in Dec. 2024 was ARS0 Mil. Johnson & Johnson paid ARS0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Johnson & Johnson's cash flow for dividends for the three months ended in Dec. 2024 was ARS-3,013,840 Mil. Johnson & Johnson spent ARS3,013,840 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Johnson & Johnson's other financing for the three months ended in Dec. 2024 was ARS394,910 Mil. Johnson & Johnson received ARS394,910 Mil on other financial activities.


Johnson & Johnson Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Address
One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.